肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2021 NICE指南：阿帕鲁胺联合雄激素剥夺疗法治疗高危激素复发非转移性前列腺癌

2021-10-28 英国国家卫生与临床优化研究所 NICE官网

阿帕鲁胺阿帕鲁胺（apalutamide）

2021年10月28日NICE发布阿帕鲁胺联合雄激素剥夺疗法治疗高危激素复发非转移性前列腺癌指南。

中文标题：

2021 NICE指南：阿帕鲁胺联合雄激素剥夺疗法治疗高危激素复发非转移性前列腺癌

英文标题：

Apalutamide with androgen deprivation therapy for treating hormone-sensitive metastatic prostate cancer

发布机构：

英国国家卫生与临床优化研究所

发布日期：

2021-10-28

简要介绍：

2021年10月28日NICE发布阿帕鲁胺联合雄激素剥夺疗法治疗高危激素复发非转移性前列腺癌指南。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 NICE指南：阿帕鲁胺联合雄激素剥夺疗法治疗高危激素复发非转移性前列腺癌.pdf)] GetToolGuiderByIdResponse(projectId=1, id=ff8cd1c0022a8462, title=2021 NICE指南：阿帕鲁胺联合雄激素剥夺疗法治疗高危激素复发非转移性前列腺癌, enTitle=Apalutamide with androgen deprivation therapy for treating hormone-sensitive metastatic prostate cancer, guiderFrom=NICE官网, authorId=0, author=, summary=2021年10月28日NICE发布阿帕鲁胺联合雄激素剥夺疗法治疗高危激素复发非转移性前列腺癌指南。, cover=https://img.medsci.cn/2021111/1635742568559_1608702.jpg, journalId=0, articlesId=null, associationId=85, associationName=英国国家卫生与临床优化研究所, associationIntro=英国国家卫生与临床优化研究所（NICE，National Institute for Health and Clinical Excellence）是NHS的组织，设在伦敦和曼彻斯特。NICE成立于1999年4月1日，目标是确保每个英格兰和威尔士人平等享有NHS医疗的机会。NICE制定指南，设定质量标准，管理国家数据库，为NHS、当地权威部门和其他组织提供指南。, copyright=0, guiderPublishedTime=Thu Oct 28 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p>2021年10月28日NICE发布阿帕鲁胺联合雄激素剥夺疗法治疗高危激素复发非转移性前列腺癌指南。</p>, tagList=[TagDto(tagId=69882, tagName=阿帕鲁胺), TagDto(tagId=114510, tagName=阿帕鲁胺（apalutamide）)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=26, categoryName=泌尿外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=114510, guiderKeyword=阿帕鲁胺（apalutamide）, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2109, appHits=49, showAppHits=0, pcHits=215, showPcHits=2059, likes=0, shares=7, comments=4, approvalStatus=1, publishedTime=Mon Nov 01 13:02:32 CST 2021, publishedTimeString=2021-10-28, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Mon Nov 01 13:02:18 CST 2021, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 11:09:01 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 NICE指南：阿帕鲁胺联合雄激素剥夺疗法治疗高危激素复发非转移性前列腺癌.pdf)])
2021 NICE指南：阿帕鲁胺联合雄激素剥夺疗法治疗高危激素复发非转移性前列腺癌.pdf
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1201405, encodeId=f072120140515, content=<a href='/topic/show?id=eb8b9e810aa' target=_blank style='color:#2F92EE;'>#阿帕鲁胺#</a>联合雄激素剥夺疗法治疗高危激素复发非转移性<a href='/topic/show?id=c8ee32526f3' target=_blank style='color:#2F92EE;'>#前列腺癌#</a> , beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97810, encryptionId=eb8b9e810aa, topicName=阿帕鲁胺), TopicDto(id=32526, encryptionId=c8ee32526f3, topicName=前列腺癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Mar 10 15:27:17 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070228, encodeId=59ac10e02288d, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25031403865, createdName=wcq5316659, createdTime=Sun Nov 14 20:30:49 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066093, encodeId=1b4d1066093e3, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Tue Nov 02 07:03:28 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065963, encodeId=7544106596355, content=谢谢分享！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee335603873, createdName=ms3000001592172450, createdTime=Mon Nov 01 20:51:27 CST 2021, time=2021-11-01, status=1, ipAttribution=)]
    2022-03-10 医者仁者

    #阿帕鲁胺#联合雄激素剥夺疗法治疗高危激素复发非转移性#前列腺癌#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1201405, encodeId=f072120140515, content=<a href='/topic/show?id=eb8b9e810aa' target=_blank style='color:#2F92EE;'>#阿帕鲁胺#</a>联合雄激素剥夺疗法治疗高危激素复发非转移性<a href='/topic/show?id=c8ee32526f3' target=_blank style='color:#2F92EE;'>#前列腺癌#</a> , beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97810, encryptionId=eb8b9e810aa, topicName=阿帕鲁胺), TopicDto(id=32526, encryptionId=c8ee32526f3, topicName=前列腺癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Mar 10 15:27:17 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070228, encodeId=59ac10e02288d, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25031403865, createdName=wcq5316659, createdTime=Sun Nov 14 20:30:49 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066093, encodeId=1b4d1066093e3, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Tue Nov 02 07:03:28 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065963, encodeId=7544106596355, content=谢谢分享！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee335603873, createdName=ms3000001592172450, createdTime=Mon Nov 01 20:51:27 CST 2021, time=2021-11-01, status=1, ipAttribution=)]
    2021-11-14 wcq5316659

    受益匪浅

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1201405, encodeId=f072120140515, content=<a href='/topic/show?id=eb8b9e810aa' target=_blank style='color:#2F92EE;'>#阿帕鲁胺#</a>联合雄激素剥夺疗法治疗高危激素复发非转移性<a href='/topic/show?id=c8ee32526f3' target=_blank style='color:#2F92EE;'>#前列腺癌#</a> , beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97810, encryptionId=eb8b9e810aa, topicName=阿帕鲁胺), TopicDto(id=32526, encryptionId=c8ee32526f3, topicName=前列腺癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Mar 10 15:27:17 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070228, encodeId=59ac10e02288d, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25031403865, createdName=wcq5316659, createdTime=Sun Nov 14 20:30:49 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066093, encodeId=1b4d1066093e3, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Tue Nov 02 07:03:28 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065963, encodeId=7544106596355, content=谢谢分享！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee335603873, createdName=ms3000001592172450, createdTime=Mon Nov 01 20:51:27 CST 2021, time=2021-11-01, status=1, ipAttribution=)]
    2021-11-02 微探

    学习学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1201405, encodeId=f072120140515, content=<a href='/topic/show?id=eb8b9e810aa' target=_blank style='color:#2F92EE;'>#阿帕鲁胺#</a>联合雄激素剥夺疗法治疗高危激素复发非转移性<a href='/topic/show?id=c8ee32526f3' target=_blank style='color:#2F92EE;'>#前列腺癌#</a> , beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97810, encryptionId=eb8b9e810aa, topicName=阿帕鲁胺), TopicDto(id=32526, encryptionId=c8ee32526f3, topicName=前列腺癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Mar 10 15:27:17 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070228, encodeId=59ac10e02288d, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25031403865, createdName=wcq5316659, createdTime=Sun Nov 14 20:30:49 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066093, encodeId=1b4d1066093e3, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Tue Nov 02 07:03:28 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065963, encodeId=7544106596355, content=谢谢分享！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee335603873, createdName=ms3000001592172450, createdTime=Mon Nov 01 20:51:27 CST 2021, time=2021-11-01, status=1, ipAttribution=)]
    2021-11-01 ms3000001592172450

    谢谢分享！

    0

拓展阅读

2021NICE指南：阿帕鲁胺联合雄激素剥夺疗法治疗激素敏感性转移性前列腺癌

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2021-10-28